FMC inherits an established omega-3 fish oils business.
FMC Corp. (Philadelphia) has acquired EPAX AS (Oslo, Norway) for $345 million. The acquisition of an omega-3 EPA and DHA supplier will bolster FMC’s business in food and nutraceutical ingredients, which also includes functional ingredients such as cellulose, pectin, and carrageenan.
By acquiring EPAX, FMC inherits the Norwegian company’s fish oil production facilities in Alesund, Norway and Seal Sands, UK. As part of the financial agreement, EPAX will continue to supply highly concentrated fish oils to its former owner, Trygg Pharma Group AS.
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.